MODULAR MEDICAL INC
MODDNASDAQTrading Snapshot
- Day Range
- $1.92 – $1.99
- 52-Week Range
- $1.72 – $21.87
- Volume
- $3.27B
- Avg Volume
- $3.30B
- Shares Outstanding
- 5.4M
- Next Earnings
- Dec 12, 2026
Fundamentals Snapshot
- Annual Revenue
- $1M
- Last Q Revenue
- $266,737
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-10.69
- Dividend Yield
- —
- Dilution (1yr)
- +148.1%
Why Investors Own MODD
- ✓High-growth profile — revenue up -7.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 26% gross margin and 14% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
MODULAR MEDICAL INC
MODD
StockOtter · stockotter.spaceAbout MODULAR MEDICAL INC
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are situated in San Diego, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Modular Medical, Inc. (MODD) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript
Modular Medical, Inc. (MODD) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript
Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026
SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its ne
Modular Medical Secures National PBM Contract For Pivot Insulin Pump
Commercial-stage medical device manufacturer Modular Medical Inc. (NASDAQ:MODD) recently signed a significant contract with a national U.S. pharmacy benefit manager (PBM).
Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump
SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial launch of its next-ge
Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements
Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot Customization SAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD
EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades
Modular Medical, Inc. (NASDAQ:MODD) on Thursday announced that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system.